We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.
APEN

Delisted

APEN was delisted on the 3rd of April, 2023.

Back to rankings

20 hedge funds and large institutions have $19.1M invested in Apollo Endosurgery, Inc. in 2017 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

186% more funds holding

Funds holding: 7 → 20 (+13)

58% more capital invested

Capital invested by funds: $12.1M → $19.1M (+$7M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
20
Holders Change
+13
Holders Change %
+185.71%
% of All Funds
0.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
3
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$12.5M
2
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM)
Texas
+$2.9M
3
Russell Investments Group
Russell Investments Group
United Kingdom
+$1.45M
4
FPC
Falcon Point Capital
California
+$630K
5
MHP
Manatuck Hill Partners
Connecticut
+$528K

Top Sellers

Rank Fund Capital Flow
1
NHAS
Novo Holdings A/S
Denmark
-$5.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Stonepine Capital Management
Oregon
$11.1M +$12.5M +2,364,707 New
Luther King Capital Management (LKCM)
2
Luther King Capital Management (LKCM)
Texas
$2.57M +$2.9M +548,454 New
Russell Investments Group
3
Russell Investments Group
United Kingdom
$1.29M +$1.45M +275,171 New
NHAS
4
Novo Holdings A/S
Denmark
$1.28M -$5.69M -1,077,500 -80%
UOTTAIMCU
5
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$722K – – –
FPC
6
Falcon Point Capital
California
$492K +$630K +119,309 New
MHP
7
Manatuck Hill Partners
Connecticut
$468K +$528K +100,000 New
BCM
8
Bridgeway Capital Management
Texas
$463K +$417K +79,000 +395%
WIC
9
Woodmont Investment Counsel
Tennessee
$220K +$248K +47,000 New
JP Morgan Chase
10
JP Morgan Chase
New York
$119K +$137K +25,936 New
Northern Trust
11
Northern Trust
Illinois
$93K +$105K +19,854 New
AAP
12
Ardsley Advisory Partners
Connecticut
$88K +$99.3K +18,800 New
BlackRock
13
BlackRock
New York
$73K +$68K +12,873 +447%
Goldman Sachs
14
Goldman Sachs
New York
$69K +$77.3K +14,642 New
Millennium Management
15
Millennium Management
New York
$54K +$61.2K +11,589 New
Wells Fargo
16
Wells Fargo
California
$9K +$10.6K +2,000 New
RWA
17
Ropes Wealth Advisors
Massachusetts
$8K – – –
Manulife (Manufacturers Life Insurance)
18
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K +$475 +90 +101%
RE
19
RBC Europe
United Kingdom
$5 +$5 +1 New

APEN Hedge Fund Activity: Q3 2017 in Review

20 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q3 2017, worth a combined $19.1M — up 58% from $12.1M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new APEN positions and 0 closed out — a net gain of 13 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Stonepine Capital Management, opening a new position worth an estimated $12.5M. The largest seller was Novo Holdings A/S, cutting an estimated $5.69M.

  • 20 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q3 2017, up from 7 in Q2 2017.
  • Funds reported $19.1M of Apollo Endosurgery, Inc. stock for Q3 2017, up 58% quarter-over-quarter.
  • 13 funds opened new Apollo Endosurgery, Inc. positions in Q3 2017 and 0 closed out, a net change of +13 holders.
  • The largest Apollo Endosurgery, Inc. buyer in Q3 2017 was Stonepine Capital Management, an estimated $12.5M added.
  • The largest Apollo Endosurgery, Inc. seller in Q3 2017 was Novo Holdings A/S, an estimated $5.69M sold.

Based on aggregated 13F filings for Q3 2017.